https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20200710-43
1. Scrip code : 509079
Name : Gufic BioSciences Ltd.
Subject : Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
This is in reference with the Scheme of Amalgamation of Gufic Biosciences Limited (‘the Company’) with Gufic Lifesciences Private Limited (‘GLPL’) and their respective shareholders and creditors, for which ‘No Observation Letters’ have been received by BSE Limited and National Stock Exchange of India Limited vide their letters dated April 15, 2020.We are pleased to inform you that GLPL have been approved by South African Health Products Regulatory Authority (SAHPRA) to manufacture Vancomycin Inj 500mg and Vancomycin Inj 1gm, after its manufacturing facility situated at Navsari, Gujarat been inspected by the Competent Authority of Hungary, National Institute of Pharmacy and Nutrition and with this approval, GLPL can now expand its business in the territory of South Africa.
2. Scrip code : 500042
Name : BASF India Ltd
Subject : Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of 100% stake in BASF Performance Polyamides India Private Limited (formerly known as Rhodia Polymers & Specialties India Private Limited)
